Thomas Hope

Thomas Hope, MD, is a Professor in the Department of Radiology at the University of California, San Francisco (UCSF), School of Medicine. He serves as Vice Chair of Clinical Operations and Strategy, Director of Molecular Therapy, and Chief of Nuclear Medicine at the San Francisco VA Medical Center. His research focuses on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors, including the development of Ga-68 PSMA-11 and leadership in PET/MRI and PRRT programs. Dr. Hope holds certifications in Diagnostic Radiology and Nuclear Medicine from the American Board of Radiology and American Board of Nuclear Medicine.

• Education & Training: Stanford University School of Medicine (MD), UCSF Diagnostic Radiology Residency, Stanford Body MRI/Nuclear Medicine Fellowship
• Grants: Principal Investigator on NIH grants (R01CA235741, R01CA212148) and Co-PI on immunogenic priming studies (R01CA229354)
• Labs/Teams: UCSF Molecular Imaging & Radionuclide Therapy programs, PRRT and PSMA Radioligand Therapy initiatives

His research integrates molecular imaging with therapeutics, emphasizing clinical translation and diagnostic innovation. Key achievements include FDA approval of Ga-68 PSMA-11 and leadership in international consensus guidelines for PSMA PET/CT and FAP PET imaging.